LexDanaLexDanabeta
Inventor

Ryuji Osawa

Inventor
Kanagawa, JP

Overview

26→
Patents
1997–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
C12NMicroorganisms or enzymes19%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
C12YEnzymes5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G02BOptical elements, systems or apparatus1%
G02FOptical devices or arrangements for the control of light by modification of the optical properties of the media of the elements involved therein1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,676,514CDCA1-derived peptide and vaccine containing same202010,576,102KOC1-derived peptide and vaccine including same202010,576,097URLC10-derived peptide and vaccine containing same202010,206,989CDCA1 epitope peptides for Th1 cells and vaccines containing the same201910,172,926KIF20A epitope peptides for TH1 cells and vaccines containing the same201910,092,634UBE2T peptides and vaccines containing the same20189,849,166TOPK peptides and vaccines including the same20179,770,498'IMP-3 epitope peptides for TH1 cells and vaccines containing the same'20179,687,538'CDCA1 epitope peptides for Th1 cells and vaccines containing the same'20179,644,010'LY6K epitope peptides for TH1 cells and vaccines containing the same'20179,597,382'KNTC2 peptides and vaccines containing the same'20179,585,948'TOMM34 peptides and vaccines including the same'20179,561,265'KIF20A epitope peptides for TH1 cells and vaccines containing the same'20179,545,437'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'20179,458,447'MPHOSPH1 peptides and vaccines including the same'20169,427,461'TOPK peptides and vaccines including the same'20169,187,556'SEMA5B peptides and vaccines including the same'20159,125,849'TOMM34 peptides and vaccines including the same'20159,056,890'WDHD1 peptides and vaccines including the same'20159,017,688'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'20158,653,234'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'20148,563,516'Foxp3 peptide vaccine'20138,557,955'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'20138,552,146'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'20138,367,799'TEM8 peptides and vaccines comprising the same'20135,671,881'Method of manufacturing an optical isolator'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997Based in Sendri, JP· patent location history
2013–2020Patents assigned to ONCOTHERAPY SCIENCE INC (25)· patent assignee history
2013–2016Patents assigned to OSAWA RYUJI (10)· patent assignee history
2013–2016Patents assigned to TSUNODA TAKUYA (10)· patent assignee history
2013–2016Patents assigned to NAKAMURA YUSUKE (8)· patent assignee history
2013–2015Patents assigned to FUJIOKA TOMOAKI (4)· patent assignee history
2013–2019Based in Kanagawa, JP· patent location history
2013–2020Based in Kawasaki, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ONCOTHERAPY SCIENCE INC252013–2020
OSAWA RYUJIself102013–2016
TSUNODA TAKUYA102013–2016
NAKAMURA YUSUKE82013–2016
FUJIOKA TOMOAKI42013–2015
Locations
LocationPatentsSpan
Kanagawa, JP162013–2019
Kawasaki, JP92013–2020
Sendri, JP11997